| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.8M | +56.2% |
| Cost of Revenue | $47.5M | +247.3% |
| Gross Profit | -$33.8M | -591.7% |
| R&D Expense | $38.3M | +184.0% |
| SG&A Expense | $81.2M | +167.3% |
| Operating Income | -$160.2M | -228.7% |
| Pre-tax Income | -$143.0M | -0.6% |
| Income Tax | -$1.0M | — |
| Net Income | -$142.0M | +0.1% |
| EPS (Basic) | -$0.75 | +93.7% |
| EPS (Diluted) | -$0.75 | +93.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.7M | -75.9% |
| Accounts Receivable | $1.1M | +24.3% |
| Inventory | $2.4M | -92.4% |
| Current Assets | $158.8M | -30.1% |
| Total Assets | $191.6M | -25.6% |
| Current Liabilities | $51.3M | +196.3% |
| Total Liabilities | $66.3M | +37.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.8M | -124.9% |
| Capital Expenditures | $9.0M | +135.5% |
| Investing Cash Flow | -$73.8M | -90.9% |
| Financing Cash Flow | -$107K | -100.0% |
| Free Cash Flow | -$78.9M | -126.0% |
| Stockholders' Equity |
| $125.3M |
| -40.1% |